AddLife AB (STU:1AD1) FFO


STU:1AD1 AddLife AB STU:1AD1
85 GF Score
Price €14.73
GF Value €13.19
! 5 Warning Signs
View Full Analysis

What is AddLife AB FFO?

FFO (Funds from operations) only applies to REITs.

STU:1AD1
85GF Score
AddLife AB STU:1AD1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AddLife AB (STU:1AD1) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of €14.73 is trading 11.7% above its estimated GF Value™ of €13.19.

Key valuation signals for STU:1AD1:

  • FFO:
  • GF Value™: €13.19 vs. price of €14.73 (11.7% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the STU:1AD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
85GF Score

Get the complete analysis for STU:1AD1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.73
Price
€13.19
GF Value